• Issue

    American Journal of Hematology: Volume 89, Issue 7

    671-793
    July 2014
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Articles

Free Access

Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?”

Jennifer Vuong,  Yuelin Qiu,  Myanh La,  Gwen Clarke,  Dorine W. Swinkels,  George Cembrowski, 
  • Pages: 671-677
  • First Published: 19 March 2014
Free Access

Cardiac iron overload in sickle-cell disease

Antonella Meloni,  Mammen Puliyel,  Alessia Pepe,  Vasili Berdoukas,  Thomas D. Coates,  John C. Wood, 
  • Pages: 678-683
  • First Published: 25 March 2014
Free Access

MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients

Diana X. Nichols-Vinueza,  Matthew T. White,  Andrew J. Powell,  Puja Banka,  Ellis J. Neufeld, 
  • Pages: 684-688
  • First Published: 21 March 2014
Free Access

A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro

María-Isabel Moreno-Carralero,  Juan-Antonio Muñoz-Muñoz,  Nuria Cuadrado-Grande,  Rafaela López-Rodríguez,  María José Hernández-Alfaro,  Alejandro del-Castillo-Rueda,  Rafael Enríquez-de-Salamanca,  Manuel Méndez,  María-Josefa Morán-Jiménez, 
  • Pages: 689-694
  • First Published: 19 March 2014
Free Access

Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange

Peter John Miller,  Andrew Matthew Farland,  Mary Ann Knovich,  Katharine Marie Batt,  John Owen, 
  • Pages: 695-697
  • First Published: 25 March 2014
Free Access

Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults

Aazim K. Omer,  Haesook T. Kim,  Bhargavi Yalamarti,  Steven L. McAfee,  Bimalangshu R. Dey,  Karen K. Ballen,  Eyal Attar,  Yi-Bin Chen,  Thomas R. Spitzer, 
  • Pages: 698-705
  • First Published: 25 March 2014
Free Access

Single agent lenalidomide three times a week induces hematologic responses in AL amyloidosis patients on dialysis

Eben I. Lichtman,  David C. Seldin,  Anthony Shelton,  Vaishali Sanchorawala, 
  • Pages: 706-708
  • First Published: 26 March 2014
Free Access

A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease

Marvin E. Reid,  Amal El Beshlawy,  Adlette Inati,  Abdullah Kutlar,  Miguel R. Abboud,  Johnson Haynes Jr.,  Richard Ward,  Bruce Sharon,  Ali T. Taher,  Wally Smith,  Deepa Manwani,  Richard G. Ghalie, 
  • Pages: 709-713
  • First Published: 28 March 2014
Free Access

Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States

Todd M. Gibson,  Eric A. Engels,  Christina A. Clarke,  Charles F. Lynch,  Dennis D. Weisenburger,  Lindsay M. Morton, 
  • Pages: 714-720
  • First Published: 03 April 2014
Free Access

Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia

Kyle M. Walsh,  Adam J. de Smith,  Tara C. Welch,  Ivan Smirnov,  Marc J. Cunningham,  Xiaomei Ma,  Anand P. Chokkalingam,  Gary V. Dahl,  William Roberts,  Lisa F. Barcellos,  Patricia A. Buffler,  Catherine Metayer,  Joseph L. Wiemels, 
  • Pages: 721-725
  • First Published: 03 April 2014
Free Access

Bone marrow 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma

Hugo J.A. Adams,  Thomas C. Kwee,  Rob Fijnheer,  Stefan V. Dubois,  Rutger A.J. Nievelstein,  John M.H. de Klerk, 
  • Pages: 726-731
  • First Published: 08 April 2014
Open Access

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Carlo Gambacorti-Passerini,  Tim H. Brümmendorf,  Dong-Wook Kim,  Anna G. Turkina,  Tamas Masszi,  Sarit Assouline,  Simon Durrant,  Hagop M. Kantarjian,  H. Jean Khoury,  Andrey Zaritskey,  Zhi-Xiang Shen,  Jie Jin,  Edo Vellenga,  Ricardo Pasquini,  Vikram Mathews,  Francisco Cervantes,  Nadine Besson,  Kathleen Turnbull,  Eric Leip,  Virginia Kelly,  Jorge E. Cortes, 
  • Pages: 732-742
  • First Published: 08 April 2014
Free Access

Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL study

Massimo Gentile,  Giovanna Cutrona,  Laura Mosca,  Serena Matis,  Sonia Fabris,  Marta Lionetti,  Fiorella Ilariucci,  Simona Zupo,  Caterina Musolino,  Luciano Levato,  Stefano Molica,  Francesco Di Raimondo,  Iolanda Vincelli,  Nicola Di Rienzo,  Emanuela Anna Pesce,  Francesco Angrilli,  Massimo Federico,  Antonino Neri,  Manlio Ferrarini,  Fortunato Morabito, 
  • Pages: 743-750
  • First Published: 08 April 2014
Free Access

Clinical profiles of multiple myeloma in Asia—An Asian Myeloma Network study

Kihyun Kim,  Jae Hoon Lee,  Jin Seok Kim,  Chang Ki Min,  Sung Soo Yoon,  Kazuyuki Shimizu,  Takaaki Chou,  Hiroshi Kosugi,  Kenshi Suzuki,  Wenming Chen,  Jian Hou,  Jin Lu,  Xiao-Jun Huang,  Shang-Yi Huang,  Wee Joo Chng,  Daryl Tan,  Gerrard Teoh,  Chor Sang Chim,  Weerasak Nawarawong,  Noppadol Siritanaratkul,  Brian G. Durie, 
  • Pages: 751-756
  • First Published: 09 April 2014
Free Access

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells

Clive S. Zent,  Ronald P. Taylor,  Margaret A. Lindorfer,  Paul V. Beum,  Betsy LaPlant,  Wenting Wu,  Timothy G. Call,  Deborah A. Bowen,  Michael J. Conte,  Lori A. Frederick,  Brian K. Link,  Sue E. Blackwell,  Suresh Veeramani,  Nisar A. Baig,  David S. Viswanatha,  George J. Weiner,  Thomas E. Witzig, 
  • Pages: 757-765
  • First Published: 10 April 2014
Open Access

A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers

Kenneth M. Attie,  Mark J. Allison,  Ty McClure,  Ingrid E. Boyd,  Dawn M. Wilson,  Amelia E. Pearsall,  Matthew L. Sherman, 
  • Pages: 766-770
  • First Published: 09 April 2014

Annual Clinical Updates in Hematological Malignancies

A Continuing Medical Education Series

Free Access

Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management

Stephen M. Ansell, 
  • Pages: 771-779
  • First Published: 21 June 2014

Clinical Pearls in Blood Diseases

Free Access

Salmonella colonies in a bone marrow film

Niharendu Ghara,  Sophie Portsmore,  Anne Yardumian,  Barbara J. Bain, 
  • Pages: 780-781
  • First Published: 11 April 2014
Free Access

Chromogenic factor VIII activity assay

Karen A. Moser,  Dorothy M. (Adcock) Funk, 
  • Pages: 781-784
  • First Published: 27 March 2014
Free Access

Heparin, warfarin, or calciphylaxis?

Rory Crotty,  Rosalynn M. Nazarian,  Philip I. Song,  Elizabeth M. Van Cott, 
  • Pages: 785-786
  • First Published: 28 January 2014
Free Access

Iatrogenic lymphoproliferative disorder

Kamyar Nader,  Danielle Smith Behrens,  Chady Abboud Leon,  Roland Schwarting,  Andres Ferber, 
  • Pages: 787-788
  • First Published: 11 April 2014

Correspondence

Free Access

IV Iron in pregnancy: An unmet clinical need

Michael Auerbach, 
  • Page: 789
  • First Published: 25 April 2014
Free Access

Reduction in serum IL-10 levels is a surrogate marker for predicting vaso-occlusive crisis in sickle cell disease

Sameh Sarray,  Najat Mahdi,  Layal R. Saleh,  Wassim Y. Almaoui, 
  • Pages: 789-790
  • First Published: 10 April 2014

Erratum

Free Access

Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death

  • Pages: 791-793
  • First Published: 21 June 2014